ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...

Driven by the rapid growth of the biopharmaceutical market and the interest of industry stakeholders, the adoption of ...

Nuage Therapeutics, a biotech company creating transformational precision therapies, has appointed Stuart Hughes as CEO and ...